Columbia Seligman Premium Technology Growth Fund Announces a Special Fourth Quarter DistributionBusiness Wire • 12/06/24
STK: A Technology Equity Fund With Call Overwrite, A 5.5% Yield And Solid GrowthSeeking Alpha • 11/17/24
Columbia Seligman Premium Technology Growth Fund Announces a Fourth Quarter Distribution: 9.25% Annual Rate for IPO InvestorsBusiness Wire • 11/08/24
Columbia Seligman Premium Technology Growth Fund Announces a Third Quarter Distribution: 9.25% Annual Rate for IPO InvestorsBusiness Wire • 08/09/24
Columbia Seligman Premium Technology Growth Fund, Inc. Holds 14th Annual Meeting of StockholdersBusiness Wire • 06/25/24
PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia VeraBusiness Wire • 06/25/24
Columbia Seligman Premium Technology Growth Fund Announces a Second Quarter Distribution: 9.25% Annual Rate for IPO InvestorsBusiness Wire • 05/03/24
Columbia Seligman Premium Technology Growth Fund, Inc. Announcements Regarding 14th Annual Meeting of StockholdersBusiness Wire • 03/14/24
Columbia Seligman Premium Technology Growth Fund Announces a First Quarter Distribution: 9.25% Annual Rate for IPO InvestorsBusiness Wire • 02/09/24